CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma

被引：0
|
作者：
YueGuo Li
Hai Peng Yu
Peng Zhang
机构：
[1] Tianjin Medical University Cancer Institute and Hospital,Department of Clinical Laboratory
[2] National Clinical Research Center for Cancer,Department of Interventional Therapy
[3] Key Laboratory of Cancer Prevention and Therapy,undefined
[4] The National “863” Program of Clinical Research Laboratory,undefined
[5] Tianjin Medical University Cancer Institute and Hospital,undefined
[6] National Clinical Research Center for Cancer,undefined
[7] Key Laboratory of Cancer Prevention and Therapy,undefined
[8] The National “863” Program of Clinical Research Laboratory,undefined
来源：
Hepatology International | 2016年 / 10卷
关键词：
Hepatocellular carcinoma; CCL15; Immunohistochemistry; Survival time;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：488 / 492
页数：4
相关论文
共 50 条
  • [31] Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma
    Cui, Xiao
    Hu, Zhi-Ping
    Li, Zhao
    Gao, Peng-Ji
    Zhu, Ji-Ye
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (28) : 8588 - 8604
  • [32] Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients
    Zi-Li He
    [J]. World Journal of Gastroenterology, 2009, 15 (33) : 4177 - 4182
  • [33] Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma
    Long-Hui Zhang
    Dong Wang
    Zhao Li
    Gang Wang
    Ding-Bao Chen
    Qian Cheng
    Shi-Hua Hu
    Ji-Ye Zhu
    [J]. Hepatobiliary & Pancreatic Diseases International, 2021, 20 (04) : 337 - 344
  • [34] Overexpression of RHEB is associated with metastasis and poor prognosis in hepatocellular carcinoma
    Liu, Fuchen
    Pan, Zeya
    Zhang, Jinmin
    Ni, Junsheng
    Wang, Chao
    Wang, Zhenguang
    Gu, Fangming
    Dong, Wei
    Zhou, Weiping
    Liu, Hui
    [J]. ONCOLOGY LETTERS, 2018, 15 (03) : 3838 - 3845
  • [35] Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma
    Zhang, Long-Hui
    Wang, Dong
    Li, Zhao
    Wang, Gang
    Chen, Ding-Bao
    Cheng, Qian
    Hu, Shi-Hua
    Zhu, Ji-Ye
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2021, 20 (04) : 337 - 344
  • [36] Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
    Chen, Jiewei
    Huang, Chuqiang
    Chen, Keming
    Li, Shuman
    Zhang, Xinke
    Cheng, Jun
    Cai, Muyan
    Xiao, Yongbo
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 441 - 448
  • [37] Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma
    Yi, Huo-Chun
    Liu, Ya-Li
    You, Pan
    Pan, Jin-Shui
    Zhou, Jian-Yan
    Liu, Zhen-Jin
    Zhang, Zhong-Ying
    [J]. MOLECULAR MEDICINE REPORTS, 2015, 11 (02) : 1318 - 1323
  • [38] KRT15 overexpression predicts poor prognosis in colorectal cancer
    Rao, X.
    Wang, J.
    Song, H. M.
    Deng, B.
    Li, J. G.
    [J]. NEOPLASMA, 2020, 67 (02) : 410 - 414
  • [39] Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
    Zhang, Zhen-Hai
    Wu, Ya-Guang
    Qin, Cheng-Kun
    Rong, Zhong-Hou
    Su, Zhong-Xue
    Xian, Guo-Zhe
    [J]. ONCOLOGY LETTERS, 2014, 8 (05) : 2160 - 2164
  • [40] Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
    Song, Huangqin
    Zhao, Haichao
    Chen, Changzhou
    Zhang, Donglin
    Wang, Xiaoxiao
    He, Jiefeng
    [J]. MEDICINE, 2023, 102 (07) : E33004
12345